James F Holsinger Md Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1603 Morgan Street, Suite 3, Keokuk, IA 52632 Phone: 319-524-4300 Fax: 319-524-4424 |
Bfm Dba Keokuk Medical Center Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1414 Main St, Keokuk, IA 52632 Phone: 319-376-1149 |
Blessing Health Keokuk Clinic Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 1414 Main St, Keokuk, IA 52632 Phone: 319-524-0123 |
Quincy Medical Group Keokuk Affiliate Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 1603 Morgan St Ste 3, Keokuk, IA 52632 Phone: 319-524-4300 Fax: 319-524-4424 |
Tri-state Medical Group Inc Family Medicine Medicare: Medicare Enrolled Practice Location: 400 N 17th St, Keokuk, IA 52632 Phone: 319-524-5734 Fax: 319-524-5758 |
Charles F Eddingfield Md General Practice Medicare: Not Enrolled in Medicare Practice Location: 1610 Morgan Street, Keokuk, IA 52632 Phone: 319-524-7777 Fax: 319-524-7782 |
Henry County Health Center, Inc. Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 3285 Main St, Keokuk, IA 52632 Phone: 319-524-6274 |
Dr. John Lee Md Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 484 Messenger Rd, Keokuk, IA 52632 Phone: 319-524-6311 Fax: 319-524-0868 |
Blessing Health Keokuk Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 1414 Main St, Keokuk, IA 52632 Phone: 319-524-0123 |
Tri-state Medical Group Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1603 Morgan St, Suite 7, Keokuk, IA 52632 Phone: 319-524-5734 Fax: 319-524-5758 |
News Archive
Sangamo BioSciences, Inc. announced today that data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo's zinc finger nuclease (ZFN) based product, SB-728-T, for HIV/AIDS were inadvertently and prematurely disclosed on the internet.
MassBiologics of the University of Massachusetts Medical School has received an orphan drug designation from the U.S. Food and Drug Administration for MBL-HCV1, a monoclonal antibody developed to prevent hepatitis C virus recurrence in patients receiving a liver transplant.
XenoPort, Inc. announced today that it has initiated a Phase 2 clinical trial of XP23829, its proprietary investigational next-generation fumaric acid product candidate. The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of XP23829 as a potential treatment of patients with moderate-to-severe chronic plaque-type psoriasis.
A mysterious disease that has killed nearly 60 children in Cambodia has been identified by the World Health Organization as enterovirus 71. This virus is one among a family of viruses that cause a variety of illnesses, including a common childhood illness called hand, foot and mouth disease, but Andrew Bonwit, MD, pediatric infectious disease specialist at Loyola University Health System, says a fatal outcome from such illness is rare.
The Oregonian: Sue Sherman of Southwest Portland was diagnosed with pancreatic cancer last year and "joined nearly 2 million disabled Americans - at least 15,000 in Oregon - who fall into a twilight with the first monthly Social Security disability payment, for they then must wait two years to become eligible for Medicare." Many of them exhaust their savings "on the care necessary to reach a diagnosis and now cannot get private insurance."
› Verified 7 days ago